November 3, 2024
Appeals court docket upholds ‘pharma bro’ Martin Shkreli lifetime ban from drug business

Martin Shkreli, former chief government officer of Turing Prescription drugs AG, exits court docket in New York, US, on Wednesday, Oct. 4, 2023. 

Yuki Iwamura | Bloomberg | Getty Photos

A federal appeals court docket on Tuesday upheld a lifetime ban on “Pharma bro” Martin Shkreli from working within the prescribed drugs business.

The ruling by a three-judge panel on the 2nd U.S. Circuit Courtroom of Appeals got here two years after a federal decide slapped the ban on Shkreli for the monopolistic conduct of his then-drug firm in promoting the medicine Daraprim.

The Federal Commerce Fee and 7 states, amongst them New York and California, had sued Shkreli within the case.

That is breaking information. Please test again for updates.